Memory and mood during the night and in the morning after repeated evening doses of MDMA

Journal of Psychopharmacology

Volumn 22, Issue 8, 2008, Pages 895-903

  Kuypers, K P C ^a   Wingen, M ^a   Ramaekers, J G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

MDMA; Memory; Repeated dose; Sleep deprivation; Spatial; Verbal

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; PLACEBO;

ADULT; ANXIETY; AROUSAL; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONFUSION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEMORY; MEMORY DISORDER; MOOD; NORMAL HUMAN; PRIORITY JOURNAL; SLEEP DEPRIVATION; SPATIAL MEMORY; VERBAL MEMORY;

ADULT; AFFECT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MEMORY; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; REGRESSION ANALYSIS; SLEEP DEPRIVATION;

EID: 54249097367     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/02698811080220081401     Document Type: Article

References (25)

1. Cami J., Farre M., Mas M., Roset P.N., Poudevida S., Mas A., San L., de la Torre R. (2000) Human pharmacology of 3,4-methylenedioxymethamphetamine ('ecstasy'). psychomotor performance and subjective effects. J Clin Psychopharmacol 20: 455-466
2. Cole J.C., Sumnall H.R. (2003) Altered states: the clinical effects of Ecstasy. Pharmacol Ther 98: 35-58
3. de Jong P.F., Das Smaal E.A. (1995) Attention and intelligence: The validity of the Star Counting Test. J Edu Psychol 87: 80-92
4. de la Torre R., Farre M., Ortuno J., Mas M., Brenneisen R., Roset P.N., Segura J., Cami J. (2000) Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol 49: 104-109
5. de la Torre R., Farre M., Roset P.N., Pizarro N., Abanades S., Segura M., Segura J., Cami J. (2004) Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit 26: 137-144
6. de Wit H., Enggasser J.L., Richards J.B. (2002) Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27: 813-825
7. Dims (2005) DIMS Jaarbericht 2005: Trimbos institute Netherlands Institute of Mental health and Addiction, pp. 1-4
8. Durmer J.S., Dinges D.F. (2005) Neurocognitive consequences of sleep deprivation. Semin Neurol 25: 117-129
9. Farre M., De La Torre R.O., Mathuna B., Roset P.N., Peiro A.M., Torrens M., Ortuno J., Pujadas M., Cami J. (2004) Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics. Psychopharmacology (Berl) 173: 364-375
10. Gouzoulis Mayfrank E., Daumann J. (2006) The confounding problem of polydrug use in recreational ecstasy/MDMA users: A brief overview
11. Hammersley R., Ditton J., Smith I., Short E. (1999) Patterns of ecstasy use by drug users. Brit J criminol 39: 625-647
12. Kuypers K.P., Ramaekers J.G. (2007) Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected. Psychopharmacology (Berl) 189: 557-563
13. Kuypers K P C (2007) Psychedelic bliss: memory and risk taking during MDMA intoxication. In Kuypers K P C, Wingen M, Formisano E, Ramaekers J G (eds). Chapter 5. Imaging the acute effects of a single dose of MDMA on word learning - preliminary results. University of Maastricht, Maastricht, pp. 200
14. Kuypers K P C, Ramaekers J.G. (2005) Transient memory impairment after acute dose of 75 mg 3.4-Methylene-dioxymethamphetamine. J Psychopharmacol 19: 633-639
15. Kuypers K P C, Wingen M., Limbert N., Samyn N., Ramaekers J.G. (2007) Acute effects of nocturnal doses of MDMA on measures of impulsivity and psychomotor performance throughout the night. Psychopharmacology (Berl) 192: 111-119
16. Lamers C.T., Ramaekers J.G., Muntjewerff N.D., Sikkema K.L., Samyn N., Read N.L., Brookhuis K.A., Riedel W.J. (2003) Dissociable effects of a single dose of ecstasy (MDMA) on psychomotor skills and attentional performance. J Psychopharmacol 17: 379-387
17. Logan B.K., Isenschmid D.S. (2003) Cocaine, methamphetamine and driving impairment. In Burns M (ed.). Medical-legal aspects of drugs, Lawyers and Judges publishing company, Tucson, US
18. Mulder-Hajonides van der Meulen W R E H., Wijnberg J.R., Hollanders J.J., DeDiana I., Hoofdakker R. (1980) Measurement of subjective sleep quality, Fifth European Congress on Sleep Research. Amsterdam
19. Parrott A.C. (2001) Human psychopharmacology of Ecstasy (MDMA). A review of 15 years of empirical research. Human Psychopharmacol Clin Experimental 16: 557-577
20. Parrott A.C. (2004) MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology 50: 329-335
21. Parrott A.C. (2006) MDMA in humans: Factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress. J Psychopharmacol 20: 147-163
22. Parrott A.C., Lasky J. (1998) Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance. Psychopharmacology (Berl) 139: 261-268
23. Sternberg S. (1966) High-speed scanning in human memory. Science 153: 652-654
24. Thomasius R., Zapletalova P., Petersen K., Buchert R., Andresen B., Wartberg L., Nebeling B., Schmoldt A. (2006) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: The longitudinal perspective. J Psychopharmacol 20: 211-225
25. Vermeeren A., Jackson J.L., Muntjewerff N.D., Quint P.J., Harrison E.M., O'Hanlon J.F. (1995) Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests. Psychopharmacology (Berl) 118: 1-9